KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI...
34 insider purchases on record · latest filing 2024-12-31.
Insiders have also filed 80 sale transactions at KALA.